Skip to main content
Leica Biosystems Histology and Pathology Product Innovation

InnovationCodes Our DNA

150+ years tackling pathology challenges head on, from better slide production to world-leading Digital Pathology empowering AI development. Our passionate experts drive our mission of Advancing Cancer Diagnostics, Improving Lives.

Alternative text here Alternative text here

Introducing our New Staining and Glass Coverslipping Workstation, the HistoCore CHROMAX WS

Enter a new era of streamlined primary staining and coverslipping:

  • Increased productivity
  • Optimized reagent consumption
  • Modern graphical user interface

DISCOVER MORE 

For In Vitro Diagnostic Use.

Integrated Solutions. Proven Performance. Reliable Results.

Customer Perspectives

Image
Dr.-Eric-Peltier-260x440-2

“Thanks to our partnership with Leica, we have access to instruments of the highest caliber. The whole approach is about the quality, traceability, and connectivity… It's a base to work on innovation and development relying on the know-how of the pathologist. We also want to develop other technologies associated with this basis. So, it can be digital pathology technologies based on artificial intelligence.”

Translated from source language.

Dr. Eric Peltier
Président Directeur Général - PRAXEA-DIAGNOSTICS

Image
Dr-Sylvia-L-Asa-MD-PhD-260x440

"Leica Biosystems products are reliable and high quality, and the company is realistic about what's required to transform traditional pathology to a digital, connected practice. I know I can count on them and trust they will be there to support me now and well into the future."

Translated from source language.

Dr. Sylvia L. Asa, MD, PhD
Consultant in Endocrine Pathology, University Hospitals Cleveland Medical Center

News & Promotions

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform

Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical trials, and through to routine diagnostics.

Learn More

Aperio GT 450 Scanner – Leading Innovation with Proven Technology

With over 25 years of Digital Pathology innovation, Leica Biosystems delivers performance and reliability.

The Aperio GT 450 scanner offers state-of-the-art enhancements, including Manual Scan capabilities, DICOM compatible files, Extended Focus for composite in-focus images, and Aperio iQC Software.

For research use only. Not for use in diagnostic procedures.

Learn More

New PD-L1 and HER2 Primary Antibodies for Cancer Research—Developed at Our Center for Enabling Precision Medicine

This milestone reflects the capabilities of our newly established Center for Enabling Precision Medicine (CEPM). Designed to foster collaboration with pharmaceutical and academic partners, the CEPM streamlines the development and delivery of immunohistochemistry assays for cancer research and diagnostics.

Learn More